We are live on ! Find out more
ISL

Ingalls & Snyder LLC Portfolio holdings

AUM $2.83B
1-Year Est. Return 21.61%
This Fund
S&P 500
This Quarter Est. Return
+9.1%
1 Year Est. Return
+21.61%
3 Year Est. Return
+166.27%
5 Year Est. Return
+212.01%
10 Year Est. Return
+695.23%
AUM
$2.14B
AUM Growth
+$116M
Cap. Flow
-$26.7M
Cap. Flow %
-1.25%
Top 10 Hldgs %
33.75%
Holding
461
New
36
Increased
115
Reduced
195
Closed
23

Top Buys

Rank Stock Value
1
DE icon
Deere & Co
DE
+$4.94M
2
STM icon
STMicroelectronics
STM
+$4.34M
3
FROG icon
JFrog
FROG
+$3.94M
4
MO icon
Altria Group
MO
+$3.73M
5
IDN icon
Intellicheck
IDN
+$3.01M

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$9.49M
2
AAPL icon
Apple
AAPL
+$9.19M
3
GM icon
General Motors
GM
+$5.02M
4
GS icon
Goldman Sachs
GS
+$4.66M
5
CSCO icon
Cisco
CSCO
+$3.79M

Sector Composition

Rank Sector Weight
1 Healthcare 22.27%
2 Technology 14.4%
3 Financials 13.66%
4 Energy 11.86%
5 Industrials 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TGB
426
Trekor Metals
TGB
$2.48B
$52K ﹤0.01%
30,236
-2,150
-7% -$3.35K
MRKR icon
427
Marker Therapeutics
MRKR
$18.8M
$34K ﹤0.01%
1,540
– –
PINS icon
428
Pinterest
PINS
$13.4B
$24K ﹤0.01%
322
+305
+1,794% +$22.7K
SPLK
429
CALL
DELISTED
Splunk Inc
SPLK
$14K ﹤0.01%
+100
New +$15.6K
UAN icon
430
CALL
CVR Partners
UAN
$1.36B
$13K ﹤0.01%
+12,800
New +$309K
SNDL icon
431
Sundial Growers
SNDL
$320M
$11K ﹤0.01%
+1,000
New +$11.9K
AGEN
432
Agenus
AGEN
$312M
– –
-10,190
Closed -$636K
ALLE icon
433
Allegion
ALLE
$13.4B
– –
-1,922
Closed -$224K
AVGO icon
434
Broadcom
AVGO
$1.85T
– –
-7,990
Closed -$350K
DBX icon
435
CALL
Dropbox
DBX
$7.6B
– –
-10,200
Closed -$226K
DOCU
436
DocuSign
DOCU
$10.5B
– –
-904
Closed -$201K
HALO icon
437
Halozyme
HALO
$9.79B
– –
-8,180
Closed -$349K
ICCC icon
438
ImmuCell
ICCC
$101M
– –
-10,000
Closed -$60K
INUV icon
439
Inuvo
INUV
$15.1M
– –
-1,297
Closed -$6K
LGND icon
440
Ligand Pharmaceuticals
LGND
$5.76B
– –
-4,472
Closed -$277K
LIQT icon
441
LiqTech
LIQT
$23M
– –
-3,490
Closed -$223K
MCHP icon
442
Microchip Technology
MCHP
$40.3B
– –
-3,100
Closed -$214K
NGVT icon
443
CALL
Ingevity
NGVT
$2.51B
– –
-2,000
Closed -$151K
NOW icon
444
ServiceNow
NOW
$115B
– –
-1,950
Closed -$215K
SCHG icon
445
Schwab US Large-Cap Growth ETF
SCHG
$59.8B
– –
-12,752
Closed -$205K
SPY icon
446
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
– –
-2,700
Closed -$1.01M
TIGO icon
447
Millicom
TIGO
$16B
– –
-12,514
Closed -$485K
TRV icon
448
Travelers Companies
TRV
$78.1B
– –
-2,040
Closed -$286K
TSM icon
449
TSMC
TSM
$2.1T
– –
-2,133
Closed -$233K
MSON
450
DELISTED
Misonix Inc
MSON
– –
-12,310
Closed -$154K
15 16 17
18
19

Similar funds

GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
AF
Aviso Financial Toronto, Ontario, Canada $2.82B AUM 24.96% 1-Year Est. Return
AIP
Atlas Infrastructure Partners London, United Kingdom $2.84B AUM 4.75% 1-Year Est. Return
SAI
Systematic Alpha Investments Princeton, New Jersey $2.84B AUM 27.03% 1-Year Est. Return
GI
GLOBALT Investments Atlanta, Georgia $2.8B AUM 21.13% 1-Year Est. Return
MWM
Meridian Wealth Management Lexington, Kentucky $2.85B AUM 31.23% 1-Year Est. Return
MSDF
Michael & Susan Dell Foundation New York $2.85B AUM 26.28% 1-Year Est. Return
SHIM
Spruce House Investment Management New York $2.8B AUM 65.68% 1-Year Est. Return

Ingalls & Snyder LLC's Q1 2021 Portfolio in Review

As of Q1 2021, Ingalls & Snyder LLC held 461 positions worth $2.14B, up 5.8% from $2.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ingalls & Snyder LLC's Q1 2021 filing shows 36 new, 115 increased, 195 reduced and 23 closed positions. Its largest new stake was JFrog: 68,342 shares worth $3.03M. The largest sale was Corcept Therapeutics, an estimated $9.49M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Technology and Financials.

  • Ingalls & Snyder LLC's largest Q1 2021 buy was JFrog: 68,342 shares worth $3.03M.
  • Ingalls & Snyder LLC added most to Deere & Co in Q1 2021, an estimated $4.94M increase.
  • Ingalls & Snyder LLC's biggest Q1 2021 reduction was Corcept Therapeutics, cutting an estimated $9.49M.
  • Ingalls & Snyder LLC fully exited Agenus in Q1 2021, selling an estimated $636K.
  • Ingalls & Snyder LLC's ten largest holdings make up 34% of its $2.14B portfolio in Q1 2021.
  • Ingalls & Snyder LLC opened 36 new positions and closed 23 in Q1 2021.
  • Ingalls & Snyder LLC's portfolio value rose 5.8% quarter-over-quarter to $2.14B.

Based on Ingalls & Snyder LLC's 13F filing for Q1 2021, filed 21 Apr 2021.